73 related articles for article (PubMed ID: 17050353)
1. A second radioisotope injection enhances intraoperative sentinel node identification in breast cancer patients without visualized nodes on preoperative lymphoscintigraphy.
Leikola JP; Leppänen EA; von Smitten KA; Leidenius MH
Acta Radiol; 2006 Oct; 47(8):760-3. PubMed ID: 17050353
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
[TBL] [Abstract][Full Text] [Related]
3. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer.
Goyal A; Newcombe RG; Mansel RE; Chetty U; Ell P; Fallowfield L; Kissin M; Sibbering M;
Eur J Cancer; 2005 Jan; 41(2):238-43. PubMed ID: 15661548
[TBL] [Abstract][Full Text] [Related]
4. Adjusting the radioisotope tracer dose according to the body mass index does not enhance the visualization of axillary sentinel lymph nodes.
Leikola JP; Leppänen EA; von Smitten KA; Leidenius MH
Acta Radiol; 2006 Sep; 47(7):646-9. PubMed ID: 16950697
[TBL] [Abstract][Full Text] [Related]
5. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
[TBL] [Abstract][Full Text] [Related]
6. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage.
Valdés Olmos RA; Tanis PJ; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kooi ML; Kroon BB
Nucl Med Commun; 2001 May; 22(5):579-86. PubMed ID: 11388582
[TBL] [Abstract][Full Text] [Related]
7. The clinical value of parasternal sentinel node biopsy in breast cancer.
Leidenius MH; Krogerus LA; Toivonen TS; Leppänen EA; von Smitten KA
Ann Surg Oncol; 2006 Mar; 13(3):321-6. PubMed ID: 16485152
[TBL] [Abstract][Full Text] [Related]
8. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
[TBL] [Abstract][Full Text] [Related]
9. Immediate dynamic lymphoscintigraphy delivers no additional value to lymphoscintigraphy 3 hr after tracer injection in sentinel lymph node biopsy in breast cancer patients.
Doting MH; Stiekema HM; de Vries J; Lemstra C; Hoekstra HJ; Vrieling M; Rietman L; Jager PL
J Surg Oncol; 2007 May; 95(6):469-75. PubMed ID: 17192946
[TBL] [Abstract][Full Text] [Related]
10. Safety of sentinel node biopsy in breast cancer patients who receive a second radioisotope injection after visualization failure in lymphoscintigraphy.
Meretoja TJ; Joensuu H; Heikkilä PS; Leidenius MH
J Surg Oncol; 2010 Nov; 102(6):649-55. PubMed ID: 20976732
[TBL] [Abstract][Full Text] [Related]
11. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
12. Additional tracer injection to improve the technical success rate of lymphoscintigraphy for sentinel node biopsy in breast cancer.
Heuts EM; van der Ent FW; van der Pol HA; von Meyenfeldt MF; Voogd AC
Ann Surg Oncol; 2009 May; 16(5):1156-63. PubMed ID: 19259741
[TBL] [Abstract][Full Text] [Related]
13. Lymphoscintigraphy does not enhance sentinel node identification or alter management of patients with early breast cancer.
Shoher A; Diwan A; Teh BS; Lu HH; Fisher R; Lucci A
Curr Surg; 2006; 63(3):207-12. PubMed ID: 16757375
[TBL] [Abstract][Full Text] [Related]
14. The impact of radiopharmaceutical particle size on the visualization and identification of sentinel nodes in breast cancer.
Leidenius MH; Leppänen EA; Krogerus LA; Smitten KA
Nucl Med Commun; 2004 Mar; 25(3):233-8. PubMed ID: 15094440
[TBL] [Abstract][Full Text] [Related]
15. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.
Pijpers R; Meijer S; Hoekstra OS; Collet GJ; Comans EF; Boom RP; van Diest PJ; Teule GJ
J Nucl Med; 1997 Mar; 38(3):366-8. PubMed ID: 9074519
[TBL] [Abstract][Full Text] [Related]
16. Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol.
Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
Clin Nucl Med; 2001 Apr; 26(4):293-8. PubMed ID: 11290886
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy.
Haigh PI; Hansen NM; Giuliano AE; Edwards GK; Ye W; Glass EC
J Nucl Med; 2000 Oct; 41(10):1682-8. PubMed ID: 11037998
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer.
van Rijk MC; Tanis PJ; Nieweg OE; Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
J Surg Oncol; 2006 Sep; 94(4):281-6. PubMed ID: 16917875
[TBL] [Abstract][Full Text] [Related]
19. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
[TBL] [Abstract][Full Text] [Related]
20. [Sentinel lymph node biopsy in breast cancer: the Lausanne experience].
Delaloye JF; Antonescu C; Besseghir N; Genton CY; Bischof-Delaloye A; De Grandi P
Rev Med Suisse Romande; 2000 Jun; 120(6):491-4. PubMed ID: 11014092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
